Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 35 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Serum levels of human MIC-1/GDF15 vary in a diurnal pattern, do not display a profile suggestive of a satiety factor and are related to BMITsai, V.; Macia, L.; Feinle-Bisset, C.; Manandhar, R.; Astrup, A.; Raben, A.; Lorenzen, J.; Schmidt, P.; Wiklund, F.; Pedersen, N.; Campbell, L.; Kriketos, A.; Xu, A.; Zhou, P.; Jia, W.; Curmi, P.; Angstmann, C.; Lee-Ng, K.; Zhang, H.; Marquis, C.; et al.; Young, M.
2022Universal Subsidized Continuous Glucose Monitoring Funding for Young People With Type 1 Diabetes: Uptake and Outcomes Over 2 Years, a Population-Based StudyJohnson, S.R.; Holmes-Walker, D.J.; Chee, M.; Earnest, A.; Jones, T.W.; ADDN Study Group:,; Craig, M.; Anderson, K.; Ambler, G.; Barrett, H.; Batch, J.; Bergman, P.; Cameron, F.; Colman, P.; Conwell, L.; Cooper, C.; Couper, J.; Davis, E.; de Bock, M.; Donaghue, K.; et al.
2012Death adder envenoming causes neurotoxicity not reversed by antivenom - Australian snakebite project (ASP-16)Johnston, C.; O'Leary, M.; Brown, S.; Currie, B.; Halkidis, L.; Whitaker, R.; Close, B.; Isbister, G.; Nagree, Y.; Ker, F.; Greene, S.; Taylor, M.; Macrokanis, C.; Wilke, G.; Coulson, A.; Barnes, C.; Bonni, R.; Whitake, R.; Halkidis, L.; Isbiste, G.; et al.; de Silva, J.
2015TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targetsYeung, D.; Osborn, M.; White, D.; Branford, S.; Braley, J.; Herschtal, A.; Kornhauser, M.; Issa, S.; Hiwase, D.; Hertzberg, M.; Schwarer, A.; Filshie, R.; Arthur, C.; Kwan, Y.; Trotman, J.; Forsyth, C.; Taper, J.; Ross, D.; Beresford, J.; Tam, C.; et al.
2012Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculatureKazenwadel, J.; Secker, G.; Liu, Y.; Rosenfeld, J.; Wildin, R.; Cuellar-Rodriguez, J.; Hsu, A.; Dyack, S.; Fernandez, C.; Chong, C.; Babic, M.; Bardy, P.; Shimamura, A.; Zhang, M.; Walsh, T.; Holland, S.; Hickstein, D.; Horwitz, M.; Hahn, C.; Scott, H.; et al.
2015A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adultsPerez-Andreu, V.; Roberts, K.; Xu, H.; Smith, C.; Zhang, H.; Yang, W.; Harvey, R.; Payne-Turner, D.; Devidas, M.; Cheng, I.; Carroll, W.; Heerema, N.; Carroll, A.; Raetz, E.; Gastier-Foster, J.; Marcucci, G.; Bloomfield, C.; Mrozek, K.; Kohlschmidt, J.; Stock, W.; et al.
2011SHP-1 expression accounts for resistance to imatinib treatment in Philadelphia chromosome-positive cells derived from patients with chronic myeloid leukemiaEsposito, N.; Colavita, I.; Quintarelli, C.; Sica, A.; Peluso, A.; Luciano, L.; Picardi, M.; Vecchio, L.; Buonomo, T.; Hughes, T.; White, D.; Radich, J.; Russo, D.; Branford, S.; Saglio, G.; Vaz de Melo, J.; Martinelli, R.; Ruoppolo, M.; Kalebic, T.; Martinelli, G.; et al.
2015Characterisation of mutations of the phosphoinositide-3-kinase regulatory subunit, PIK3R2, in perisylvian polymicrogyria: a next-generation sequencing studyMirzaa, G.M.; Conti, V.; Timms, A.E.; Smyser, C.D.; Ahmed, S.; Carter, M.; Barnett, S.; Hufnagel, R.B.; Goldstein, A.; Narumi-Kishimoto, Y.; Olds, C.; Collins, S.; Johnston, K.; Deleuze, J.F.; Nitschké, P.; Friend, K.; Harris, C.; Goetsch, A.; Martin, B.; Boyle, E.A.; et al.
2015HPV.edu study protocol: a cluster randomised controlled evaluation of education, decisional support and logistical strategies in school-based human papillomavirus (HPV) vaccination of adolescentsSkinner, S.R.; Davies, C.; Cooper, S.; Stoney, T.; Marshall, H.; Jones, J.; Collins, J.; Hutton, H.; Parrella, A.; Zimet, G.; Regan, D.G.; Whyte, P.; Brotherton, J.M.L.; Richmond, P.; McCaffrey, K.; Garland, S.M.; Leask, J.; Kang, M.; Braunack-Mayer, A.; Kaldor, J.; et al.
2017Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)McElvaney, N.; Burdon, J.; Holmes, M.; Glanville, A.; Wark, P.; Thompson, P.; Hernandez, P.; Chlumsky, J.; Teschler, H.; Ficker, J.; Seersholm, N.; Altraja, A.; Mäkitaro, R.; Chorostowska-Wynimko, J.; Sanak, M.; Stoicescu, P.; Piitulainen, E.; Vit, O.; Wencker, M.; Tortorici, M.; et al.